total pharma ltd
total pharma ltd Company Information
Company Number
06914840
Website
-Registered Address
belvoir house 1 rous road, newmarket, suffolk, CB8 8DH
Industry
Manufacture of basic pharmaceutical products
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
stephen scott 100%
total pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of TOTAL PHARMA LTD at £13.1k based on a Turnover of £10.3k and 1.28x industry multiple (adjusted for size and gross margin).
total pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of TOTAL PHARMA LTD at £0 based on an EBITDA of £-27k and a 5.71x industry multiple (adjusted for size and gross margin).
total pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of TOTAL PHARMA LTD at £5 based on Net Assets of £10 and 0.56x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Total Pharma Ltd Overview
Total Pharma Ltd is a dissolved company that was located in suffolk, CB8 8DH with a Companies House number of 06914840. It operated in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in May 2009, it's largest shareholder was stephen scott with a 100% stake. The last turnover for Total Pharma Ltd was estimated at £10.3k.
Upgrade for unlimited company reports & a free credit check
Total Pharma Ltd Health Check
Pomanda's financial health check has awarded Total Pharma Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £10.3k, make it smaller than the average company (£22.9m)
- Total Pharma Ltd
£22.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -54%, show it is growing at a slower rate (5.8%)
- Total Pharma Ltd
5.8% - Industry AVG
Production
with a gross margin of 40.4%, this company has a comparable cost of product (40.4%)
- Total Pharma Ltd
40.4% - Industry AVG
Profitability
an operating margin of -262.6% make it less profitable than the average company (7.8%)
- Total Pharma Ltd
7.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (108)
- Total Pharma Ltd
108 - Industry AVG
Pay Structure
on an average salary of £49.1k, the company has an equivalent pay structure (£49.1k)
- Total Pharma Ltd
£49.1k - Industry AVG
Efficiency
resulting in sales per employee of £10.3k, this is less efficient (£287.4k)
- Total Pharma Ltd
£287.4k - Industry AVG
Debtor Days
it gets paid by customers after 8 days, this is earlier than average (59 days)
- Total Pharma Ltd
59 days - Industry AVG
Creditor Days
its suppliers are paid after 340 days, this is slower than average (41 days)
- Total Pharma Ltd
41 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Total Pharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Total Pharma Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 99.8%, this is a higher level of debt than the average (50.5%)
99.8% - Total Pharma Ltd
50.5% - Industry AVG
TOTAL PHARMA LTD financials
Total Pharma Ltd's latest turnover from March 2018 is estimated at £10.3 thousand and the company has net assets of £10. According to their latest financial statements, we estimate that Total Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 17 | 23 | 31 | 42 | 56 | 75 | 100 | 134 | 179 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 17 | 23 | 31 | 42 | 56 | 75 | 100 | 134 | 179 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 241 | 27,876 | 23,935 | 22,090 | 5,620 | 5,540 | 308 | 5,414 | 23,327 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 5,460 | 0 | 0 | 962 | 962 | 0 | 0 | 0 | 0 |
| Cash | 0 | 4,745 | 10,323 | 11,529 | 36,276 | 38,390 | 1,788 | 3,737 | 471 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 5,701 | 32,621 | 34,258 | 34,581 | 42,858 | 43,930 | 2,096 | 9,151 | 23,798 |
| total assets | 5,718 | 32,644 | 34,289 | 34,623 | 42,914 | 44,005 | 2,196 | 9,285 | 23,977 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 5,708 | 5,668 | 5,631 | 5,611 | 13,501 | 14,255 | 9,476 | 15,243 | 22,706 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 5,708 | 5,668 | 5,631 | 5,611 | 13,501 | 14,255 | 9,476 | 15,243 | 22,706 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 27 | 38 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 27 | 38 |
| total liabilities | 5,708 | 5,668 | 5,631 | 5,611 | 13,501 | 14,270 | 9,476 | 15,270 | 22,744 |
| net assets | 10 | 26,976 | 28,658 | 29,012 | 29,413 | 29,735 | -7,280 | -5,985 | 1,233 |
| total shareholders funds | 10 | 26,976 | 28,658 | 29,012 | 29,413 | 29,735 | -7,280 | -5,985 | 1,233 |
| Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 6 | 8 | 11 | 14 | 19 | 25 | 34 | 45 | 21 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -22,175 | 3,941 | 883 | 16,470 | 1,042 | 5,232 | -5,106 | -17,913 | 23,327 |
| Creditors | 40 | 37 | 20 | -7,890 | -754 | 4,779 | -5,767 | -7,463 | 22,706 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | -15 | 15 | -27 | -11 | 38 |
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | -4,745 | -5,578 | -1,206 | -24,747 | -2,114 | 36,602 | -1,949 | 3,266 | 471 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,745 | -5,578 | -1,206 | -24,747 | -2,114 | 36,602 | -1,949 | 3,266 | 471 |
total pharma ltd Credit Report and Business Information
Total Pharma Ltd Competitor Analysis
Perform a competitor analysis for total pharma ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other undefined companies, companies in CB8 area or any other competitors across 12 key performance metrics.
total pharma ltd Ownership
TOTAL PHARMA LTD group structure
Total Pharma Ltd has no subsidiary companies.
Ultimate parent company
TOTAL PHARMA LTD
06914840
total pharma ltd directors
Total Pharma Ltd currently has 2 directors. The longest serving directors include Mr Stephen Scott (May 2009) and Mr John Carter (May 2009).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Stephen Scott | 62 years | May 2009 | - | Director | |
| Mr John Carter | United Kingdom | 67 years | May 2009 | - | Director |
P&L
March 2018turnover
10.3k
-92%
operating profit
-27k
0%
gross margin
40.5%
+3.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2018net assets
10
-1%
total assets
5.7k
-0.82%
cash
0
-1%
net assets
Total assets minus all liabilities
Similar Companies
total pharma ltd company details
company number
06914840
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
May 2009
age
15
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
March 2018
address
belvoir house 1 rous road, newmarket, suffolk, CB8 8DH
accountant
-
auditor
-
total pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to total pharma ltd.
total pharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
